Vistin Pharma
24,2 NOK -2,02 %Vær den første som følger denne virksomhed
Vistin Pharma is a Norwegian pharmaceutical company. The company conducts research and development as well as further production of pharmaceutical substances (API), mainly the substances metformin, codeine phosphate, and Pholcodine. The substances are mainly used in the treatment of diabetes. The company operates worldwide, with the largest presence in the Nordic market. Vistin Pharma was founded in 2015 and is headquartered in Oslo, Norway.
Omsætning
304,85 mio.
EBIT %
-2 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
Oslo Børs
VISTN
Daglig lav / høj pris
24 / 25
NOK
Markedsværdi
1,07 mia. NOK
Aktieomsætning
946,88 t NOK
Volumen
39 t
Finanskalender
Delårsrapport
23.08.2023
Delårsrapport
26.10.2023
Viser Alle indholdstyper